Imunon CEO receives stock grant in lieu of cash
Lindborg Stacy reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lindborg Stacy reported acquisition or exercise transactions in this Form 4 filing.
Imunon, Inc. President and CEO Stacy Lindborg reported a stock-based compensation grant on Common Stock. She was awarded 67,150 shares at $1.72 per share as stock granted in lieu of cash for 50% of her 2025 annual cash bonus. Following this grant, she directly holds 74,188 shares of Common Stock. She also has an indirect holding of 778 shares through a 401(k) plan, which reflects plan holdings rather than a new market transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 67,150 | $1.72 | $115K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Stock granted in lieu of cash for 50% of 2025 annual cash bonus
Key Figures
Key Terms
Grant, award, or other acquisition financial
401(k) Plan financial
Common Stock financial
annual cash bonus financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Imunon (IMNN) CEO Stacy Lindborg report?
Is the Imunon (IMNN) CEO’s Form 4 transaction an open-market purchase or sale?
How is the Imunon (IMNN) CEO’s 401(k) holding reflected in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.